DocGo
DocGo is a leading provider of last-mile mobile health services and integrated medical mobility solutions. DocGo’s Mobile Health bridges the gap between telemedicine visits and in-person treatments by fully integrating with industry-leading EHR providers to enable seamless care logistics. Our AI-powered transportation and concierge medical services enable our clinical professionals to facilitate high-quality patient-centered care, helping improve patient outcomes while reducing the total cost of care for our customers.
Nasdaq: DCGO
IR Website: https://ir.docgo.com
Headquarters: New York, NY
Content provided by DocGo on 1-28-22.
TALK TO MANAGEMENT
The DocGo management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.
Summary
DocGo is a leading provider of last-mile mobile health services and integrated medical mobility solutions. DocGo’s Mobile Health bridges the gap between telemedicine visits and in-person treatments by fully integrating with industry-leading EHR providers to enable seamless care logistics. Our AI-powered transportation and concierge medical services enable our clinical professionals to facilitate high-quality patient-centered care, helping improve patient outcomes while reducing the total cost of care for our customers.
Where long waits in busy emergency rooms do more harm than good, we go. Where underserved populations need better care, we go. Where homebound populations benefit from onsite treatment, we go. Where basic telehealth providers stop, we go. And when all reason says it can’t be done, leave well enough alone and quit while you’re ahead, we do what our company has always done. We go.
Recent News
DocGo Announces Record Preliminary Fourth Quarter 2021 Revenue
Jan 28, 2022
DocGo to Acquire Mid Atlantic Care and Expand Footprint to Two New Markets.
Jan 27, 2022
DocGo Expands Mobile Health Services to Aetna Customers in New York and New Jersey
Jan 17, 2022
DocGo Provides Advanced Life Support Vehicles to Assist Upstate New York Hospitals
Jan 11, 2022
DocGo Announces Upcoming Presentation at the Needham Virtual Growth Conference
Jan 06, 2022
Management Overview
Stan Vashovsky
CEO & CoFounder
Stan Vashovsky co-founded Ambulnz in 2015 with the vision to revolutionize medical transportation and mobile healthcare delivery. During his undergraduate studies, Mr. Vashovsky founded Medcare, a medical technology company that was acquired by Philips Healthcare in 2005. He then continued to serve as vice president of software innovation at Philips for over six years. Mr. Vashovsky also conducted a turnaround of Health Systems Solutions, a public company, which ultimately led to a successful sale to a private equity firm. Mr. Vashovsky has over 25 years of healthcare technology experience and spent over 20 years as a volunteer paramedic.
Andre Oberholzer
CFO, DocGo Inc.
Mr. Oberholzer has been CFO for DocGo since 2015 and brings more than 30 years of senior financial and operational experience to the company. He manages the company’s corporate, financing, and strategic projects, and has assisted DocGo from its conception. Before joining DocGo, he held CFO roles for several companies in various stages of development ranging from start-ups to large global enterprises. From 2006 to 2012, he was CFO at a division of Altegrity where he was responsible for restructuring and strategic projects.
Anthony Capone
President, CTO & CPO
Anthony Capone has served as Ambulnz’s president, CTO, and CPO since 2017. He is an operational lead for Ambulnz COVID Response across the US, including Ambulnz’s work with FEMA’s New York State COVID deployment. He has built one of the nation’s largest ambulance companies, managed technology at five companies from start-up to acquisition, spoken at dozens of conferences globally, including the prestigious SALT Conference, founded the largest free developer conference in the USA, Engineers4Engineers, and raised hundreds of millions of dollars in assets under management.
Norm Rosenberg
CFO
Mr. Rosenberg became the CFO for Ambulnz in January 2020. Prior to Ambulnz, he spent five years at AmTrust Financial, Inc. in a variety of roles including as the president of their direct-to-consumer division and CFO of fee companies. In his role of CFO, he was responsible for the divestitures of several non-core units, resulting in proceeds of more than $1 billion. Mr. Rosenberg has served as CFO for companies like KDDI Global, Marsh, Inc., and IDT Telecom.
Dr. Mark Merlin
Chief Medical Officer
Dr. Mark Merlin serves as the Chief Medical Officer of DocGo and the CEO of the nonprofit MD1, a national in-field physician response program. Dr. Merlin is an international lecturer on prehospital physician response and the founder and former program director of the largest EMS fellowship in the United States. He provides medical direction for Angel MedFlight and Medway Air-Medical Transport and has consulted on numerous legal cases involving malpractice and intellectual property. Dr. Merlin is a national medical consultant for FOX, NBC, and CBS. Previously, he served as the Chief Medical Officer of MONOC, New Jersey’s largest EMS system.
Risks & Disclosures
This communication is neither an offer to sell nor a solicitation of an offer to buy, nor a recommendation of any securities of the company mentioned herein.
DocGo (the “Company”) and its counsel have reviewed the content of this page as well as the accompanying presentation (“Company Presentation”) displayed on this page. To the best of its knowledge, the Company does not believe this content to be misleading or inaccurate in any material respect, nor does it believe there are any material omissions with respect to such content. The Company does not believe the contents of the page or the Company Presentation to contain any non-public material information.
Information and opinions presented in the Company Presentation are provided by the Company, and b2i digital makes no representation as to their accuracy or completeness. The information contained on this page is not intended to constitute any form of advice, and the information provided is not intended to provide a sufficient basis on which to make an investment decision. It is not investment research, nor does it constitute a research recommendation, as it does not constitute substantive research or analysis. This information is not to be relied upon in substitution for the exercise of independent judgment.
Information, opinions and estimates contained on this page or in the Company Presentation reflect judgments by the Company as of the original date of publication by the Company and are subject to change without notice. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied is made regarding future performance.
A complete description of the risks and uncertainties relating to the Company and its securities can be found in the company's filings with the U.S. Securities and Exchange Commission available for free at www.sec.gov.
Information on this page may relate to penny stocks, which may also be referred to as low-priced stocks. Penny stocks are low-priced shares typically issued by small companies. Penny stocks involve greater than normal risk, they may be less liquid than other stocks (i.e., more difficult to sell), and there may be less reliable information available regarding such stocks. Investors in penny stocks should be prepared for the possibility that they may lose their entire investment.
B2I DIGITAL, Inc. is a marketing sponsor of the Roth 34th Annual Roth Conference. B2I DIGITAL, Inc. is not an affiliate of Roth Capital Partners, LLC (“Roth”) and is not authorized to represent or act on behalf of Roth ,in any capacity. Roth has not reviewed and approved the content contained on the b2idigital.com website.